CUSIP 53220K504COM NEWLGNDQ4 2025
50 filings · latest Nov 14, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 2.94M | $555.91M |
| 2 | Vanguard Group Inc | 2.07M | $392.11M |
| 3 | Janus Henderson Group PLC | 995.4K | $188.20M |
| 4 | State Street Corp | 751.2K | $142.03M |
| 5 | Nomura Asset Management International Inc. | 644.1K | $121.78M |
| 6 | Fmr LLC | 579.2K | $109.50M |
| 7 | Chicago Capital, LLC | 561.4K | $106.15M |
| 8 | Invesco Ltd. | 516.5K | $97.65M |
| 9 | Massachusetts Financial Services Co /Ma/ |
| 4 | May 14, 2025 | Janus Henderson Group PLC | 13G/A | 5.3% | 1.03M | SEC |
| 5 | Feb 14, 2025 | Janus Henderson Group PLC | 13G/A | 5.4% | 1.02M | SEC |
| 6 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 15.6% | 2.95M | SEC |
| 7 | Nov 14, 2024 | Janus Henderson Group PLC | 13G/A | 5.5% | 1.01M | SEC |
| 8 | Nov 8, 2024 | Goldman Sachs Group Inc | 13G/A | 0.3% | 52.4K | SEC |
| 9 | Nov 1, 2024 | Macquarie Group Ltd | 13G/A | 4.9% | 887.3K | SEC |
| 10 | Feb 14, 2024 | Macquarie Group Ltd | 13G | 5.7% | 987.2K | SEC |
See the full Schedule 13D/13G history for Ligand Pharmaceuticals Inc.
Unlock full history| 507.0K |
| $95.86M |
| 10 | Stephens Investment Management Group LLC | 501.0K | $94.73M |